These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7694241)

  • 1. Infection of implantable cardioverter defibrillator systems: a preventable complication?
    Shahian DM; Williamson WA; Martin D; Venditti FJ
    Pacing Clin Electrophysiol; 1993 Oct; 16(10):1956-60. PubMed ID: 7694241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrillator generator replacements in patients with left ventricular assist device support: The risks of hematoma and infection.
    Eulert-Grehn JJ; Sterner I; Schoenrath F; Stein J; Mulzer J; Kurz S; Lanmüller P; Barthel F; Unbehaun A; Klein C; Jacobs S; Falk V; Potapov E; Starck C
    J Heart Lung Transplant; 2022 Jun; 41(6):810-817. PubMed ID: 35422347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of patients with infected implantable cardioverter-defibrillator systems.
    O'Nunain S; Perez I; Roelke M; Osswald S; McGovern BA; Brooks DR; Torchiana DF; Vlahakes GJ; Ruskin J; Garan H
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):121-9. PubMed ID: 9011681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years.
    Trappe HJ; Pfitzner P; Klein H; Wenzlaff P
    Br Heart J; 1995 Jan; 73(1):20-4. PubMed ID: 7888255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version.
    Takahashi T; Bhandari AK; Watanuki M; Cannom DS; Sakurada H; Hiraoka M
    Circ J; 2002 Aug; 66(8):746-50. PubMed ID: 12197599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal placement of an ICD generator: a solution for a difficult problem.
    DeFilippi VJ; Gottlieb L; Bump T; Ferguson MK
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):130-1. PubMed ID: 8848371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of hematoma with uninterrupted warfarin in patients undergoing implantation of subcutaneous implantable cardioverter defibrillator.
    Evenson C; Saour B; Afzal MR; Knight B; Okabe T; Weiss R
    Pacing Clin Electrophysiol; 2019 Aug; 42(8):1111-1114. PubMed ID: 31231810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
    Poole JE; Gleva MJ; Mela T; Chung MK; Uslan DZ; Borge R; Gottipaty V; Shinn T; Dan D; Feldman LA; Seide H; Winston SA; Gallagher JJ; Langberg JJ; Mitchell K; Holcomb R;
    Circulation; 2010 Oct; 122(16):1553-61. PubMed ID: 20921437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place.
    Gupta A; Subzposh F; Hankins SR; Kutalek SP
    Tex Heart Inst J; 2015 Apr; 42(2):140-3. PubMed ID: 25873825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of oral anticoagulation in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.
    Afzal MR; Mehta D; Evenson C; Pinkhas D; Badin A; Patel D; Essandoh MK; Godara H; Tyler J; Houmsse M; Liu Z; Kalbfleisch SJ; Hummel JD; Augostini R; Weiss R; Daoud EG; Okabe T
    Heart Rhythm; 2018 Apr; 15(4):520-523. PubMed ID: 29146276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants.
    Mela T; McGovern BA; Garan H; Vlahakes GJ; Torchiana DF; Ruskin J; Galvin JM
    Am J Cardiol; 2001 Oct; 88(7):750-3. PubMed ID: 11589841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
    Turagam MK; Nagarajan DV; Bartus K; Makkar A; Swarup V
    J Interv Card Electrophysiol; 2017 Aug; 49(2):197-204. PubMed ID: 28413854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The complications of implantable cardioverter-defibrillators and their treatment].
    Iorio D; Bonifazi R; Aquino TM; Santise G; Spampinato N
    G Chir; 1999 May; 20(5):238-40. PubMed ID: 10380366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center.
    Spinler SA; Nawarskas JJ; Foote EF; Sabapathi D; Connors JE; Marchlinski FE
    Clin Infect Dis; 1998 May; 26(5):1111-6. PubMed ID: 9597238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.
    Ascoeta MS; Marijon E; Defaye P; Klug D; Beganton F; Perier MC; Gras D; Algalarrondo V; Deharo JC; Leclercq C; Fauchier L; Babuty D; Bordachar P; Sadoul N; Boveda S; Piot O;
    Heart Rhythm; 2016 May; 13(5):1045-1051. PubMed ID: 26749313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage of exposed implantable cardiac electrical devices and lead systems with pocket change and local flap coverage.
    Kolker AR; Redstone JS; Tutela JP
    Ann Plast Surg; 2007 Jul; 59(1):26-9; discussion 30. PubMed ID: 17589255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.